Scandinavian Real Heart AB Logo

Scandinavian Real Heart AB

Develops a total artificial heart for patients awaiting a heart transplant.

HEART | ST

Overview

Corporate Details

ISIN(s):
SE0006256798 (+3 more)
LEI:
549300HFGZRJQVLZI163
Country:
Sweden
Address:
Kopparbergsvägen 6, 722 13 Västerås

Description

Scandinavian Real Heart AB is a medical technology company developing a total artificial heart (TAH) for patients with life-threatening, end-stage heart failure. Its main product, the Realheart® TAH, is designed to completely replace a diseased heart, primarily serving as a transitional solution for patients awaiting a heart transplant. A key innovation of the device is its ability to mimic the natural heart's function by generating a pulsatile blood flow, which is intended to more closely replicate the body's physiological circulation. The company's objective is to save lives and improve the quality of life for individuals with advanced heart conditions. The device has received a Humanitarian Use Device (HUD) designation from the U.S. Food and Drug Administration (FDA).

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Scandinavian Real Heart AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Scandinavian Real Heart AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Scandinavian Real Heart AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-01-17 Magnus Öhman Other Buy 4,500 51,300.00 SEK
2025-01-17 Magnus Öhman Other Buy 500 5,750.00 SEK
2025-01-16 Magnus Öhman Other Buy 500 5,650.00 SEK
2025-01-16 Magnus Öhman Other Buy 500 5,550.00 SEK
2025-01-16 Magnus Öhman Other Buy 500 5,515.60 SEK
2025-01-16 Magnus Öhman Other Buy 200 2,180.00 SEK
2024-11-19 Azad Najar Other Other 409,000 N/A

Peer Companies

Monogram Technologies Inc. Logo
Develops a robotic surgical platform for joint replacement with custom 3D implants.
United States of America
MGRM
Develops and commercializes medical technology intellectual property.
Switzerland
MNIN
MYOMO, INC. Logo
Develops powered orthoses to restore function for individuals with upper-limb paralysis.
United States of America
MYO
NanoEcho AB Logo
Develops a diagnostic method for rectal cancer to assess lymph node spread.
Sweden
NANECH
NanoenTek,Inc. Logo
Develops life-science lab equipment and IVD devices using lab-on-a-chip technology.
South Korea
039860
NeoDynamics AB Logo
Medical technology company focused on high-precision cancer biopsy systems.
Sweden
NEOD
Neola Medical AB Logo
Develops a non-invasive lung monitoring system for premature infants.
Sweden
NEOLA
Neuronetics, Inc. Logo
A medical technology company developing non-invasive therapies for neurohealth disorders.
United States of America
STIM
NIHON ISK Company, Limited Logo
A Japanese manufacturer of security products and dental equipment.
Japan
7986
NIOX GROUP PLC Logo
Develops medical devices for the diagnosis and management of asthma.
United Kingdom
NIOX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.